Close Menu

Beckman Coulter

The Chairman, President, and CEO resigned yesterday, but the firm did not provide the reasons for his exit.

Avantra was founded last year by Courtagen Capital Group to commercialize the assets of Decision Biomarkers, a protein biomarker technology firm that shuttered its business and filed for Chapter 7 bankruptcy in December 2009.

The firm's revenues were aided by a $116.6 million contribution from Olympus Diagnostics, which the firm bought last year. It missed analysts' estimates and offered a disappointing forecast, sending its shares down sharply.

New Products: Jul 13, 2010


Beckman DNAdvance SP, Applied Biosystems 3500 Dx Series Genetic Analyzer

Paired Ends: Jul 6, 2010


Nick Naclerio, Douglas White, Fred Walder, Yemi Adesokan, Graeme Doran, Bill Cook, Sabrina Haas, John Boyce, Jessica Tonani, Andre Marion, William Shanahan

New Products: Jun 29, 2010


Beckman Coulter's SPRIworks II, Epicenter Biotechnologies' rRNA removal kit, SoftGenetics' NextGENe

Last year, the consortium, which involves researchers, funding agencies, and industry representatives from Canada, Chile, and Norway, awarded a $6 million contract to Beckman Coulter Genomics for the first phase of the project, which uses Sanger sequencing.

The agency is requesting sequencing services on both the 454 and Illumina platforms. Beckman Coulter and Macrogen are among the companies interested in submitting proposals.

The firm reported particularly strong growth for its clinical diagnostics segment, which posted 30 percent revenue growth.

Beckman Coulter's shares dropped around 7 percent after the firm disclosed that an ongoing issue surrounding its troponin test kits could lead to further restrictions on the test and may have a material impact on its results.


A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.